Powder: -20°C for 3 years | In solvent: -80°C for 2 years
AZD4635 is a new-type adenosine 2A receptor (A2AR) inhibitor(Ki=1.7 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 118.00 | |
25 mg | In stock | $ 198.00 | |
50 mg | In stock | $ 312.00 | |
100 mg | In stock | $ 480.00 | |
500 mg | In stock | $ 1,060.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | AZD4635 is a new-type adenosine 2A receptor (A2AR) inhibitor(Ki=1.7 nM). |
Targets&IC50 | A2AR:Ki: 1.7 nM |
Synonyms | HTL1071 |
Molecular Weight | 315.74 |
Formula | C15H11ClFN5 |
CAS No. | 1321514-06-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 83.3 mg/mL (263.83 mM)
H2O: < 0.1 mg/mL (insoluble)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD4635 1321514-06-0 GPCR/G Protein Neuroscience Adenosine Receptor inhibit AZD 4635 Imaradenant HTL-1071 Inhibitor HTL 1071 P1 receptor AZD-4635 HTL1071 inhibitor